CSI Market
Sign In | Register

Virax Biolabs Group Limited (VRAX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access VRAX Annual Balance Sheets →
Quarterly balance sheet trends provide context on Virax Biolabs Group Limited's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2025)
(Mar 31 2024) 0 0 0
Assets
Cash & cash equivalent0.00
Cash, Cash Equivalents Other4.23
Cash & Short-term Investments4.00
Inventories0.09
Other Current Assets0.00
Total Current Assets4.89
Equipment/Property/Plant Net1.23
Intangible Assets0.00
Tax Assets, Noncurrent1.30
Other Assets, Noncurrent0.00
Total Assets6.43
Liabilities
Current Accounts Payable AndAccrued Liabilities0.00
Other Liabilities, Current0.00
Total Current Liabilities0.67
Total Long-term Debt0.00
Other liabilities, Noncurrent0.96
Total Liabilities0.96
Stockholders' Equity
Other Equity0.00
Common Stockholder's Equity5.46
Total Stockholder's Equity5.46
Liabilities & Stockholder's Equity6.43
4 historic quarters locked

Sign in to unlock the full Virax Biolabs Group Limited balance sheet history.

Sign In Create Free Account

About Virax Biolabs Group Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-295158

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.